DYNE THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26 USD | +0.19% |
|
-0.31% | +95.49% |
| May. 02 | Dyne Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 30 | Morgan Stanley Starts Dyne Therapeutics With Overweight Rating, $40 Price Target | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 29.18 | 29.18 | 29.13 |
| Spread/Res. | -10.90% | -10.90% | -10.74% |
| Spread/Supp. | +9.94% | +66.45% | +86.11% |
| Support | 23.65 | 15.62 | 13.97 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- DYN Stock
- Charts Dyne Therapeutics, Inc.
